Clinical characteristics and disease severity of adults with cystic fibrosis with at least one residual function mutation Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020
Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002
Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020
Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019
Lung clearance index and functional MRI outcomes to assess lung disease in preschool children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020
Impact of lung disease on respiratory impedance in young children with cystic fibrosis Source: Eur Respir J 2015; 46: 1672-1679 Year: 2015
Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015
Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018
Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018
Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Progression of lung disease detected by MRI and impact of NBS in preschool children with cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019
Sputum glucose as a marker of disease severity in adult patients with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018
Mannose binding lectin deficiency is associated with disease severity in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011
Prevalence of hyperglycaemia during infective exacerbation in adult cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007
Distribution of severity of patients with obstructive lung disease in an at risk population Source: Eur Respir J 2004; 24: Suppl. 48, 474s Year: 2004
Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Relationship between quality of life, exercise capacity and disease severity in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011
Evaluation of disease knowledge in children with cystic fibrosis and their families Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011